Graypoint LLC Grows Stake in HCA Healthcare, Inc. (NYSE:HCA)

Graypoint LLC raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,840 shares of the company’s stock after buying an additional 51 shares during the period. Graypoint LLC’s holdings in HCA Healthcare were worth $748,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of HCA. MFA Wealth Advisors LLC bought a new position in HCA Healthcare in the 2nd quarter worth $27,000. Unique Wealth Strategies LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $28,000. Bangor Savings Bank grew its position in shares of HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC grew its position in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after acquiring an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new stake in HCA Healthcare during the 2nd quarter worth $33,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.70% of the stock is currently owned by insiders.

HCA Healthcare Price Performance

Shares of HCA opened at $356.03 on Friday. The company has a 50 day moving average of $391.18 and a two-hundred day moving average of $355.72. HCA Healthcare, Inc. has a twelve month low of $226.48 and a twelve month high of $417.14. The company has a market cap of $90.18 billion, a price-to-earnings ratio of 15.99, a price-to-earnings-growth ratio of 1.39 and a beta of 1.68. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Wall Street Analysts Forecast Growth

HCA has been the subject of a number of research analyst reports. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Morgan Stanley initiated coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective for the company. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Wells Fargo & Company boosted their target price on shares of HCA Healthcare from $395.00 to $400.00 and gave the stock an “equal weight” rating in a research note on Wednesday. Finally, Leerink Partners increased their target price on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Five analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $379.39.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.